Product Information
PROCHLORPERAZINE 10 MG TAB is a generic product labeled by ANI Pharmaceuticals, Inc., priced at $0.1621 per EA under NDC 70954068910. Its NADAC has been published 203 times since Nov 16, 2022.
FDA first approved this application on Jun 13, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10 mg/1
Manufacturer
ANI Pharmaceuticals, Inc.NDC
70954068910
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
PROCHLORPERAZINE MALEATEApproval Type
Generic (ANDA)
FDA Application
ANDA216202FDA Approved
6/13/2022
TE Code
AB
On Market Since
8/1/2022
Pharmacological Classes
Price Statistics
The NADAC for PROCHLORPERAZINE 10 MG TAB has been published 203 times since Nov 16, 2022, and over the history we have for it it has declined 61.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1621 per EA |
|---|---|
| All-time high | $0.4384 (Apr 12, 2023) |
| All-time low | $0.1493 (Nov 20, 2024) |
| 52-week high | $0.2036 |
| 52-week low | $0.1621 |
| Median price | $0.2173 |
| Average price | $0.2777 |
| Largest weekly change | -40.9% (Nov 20, 2024) |
| Weeks tracked | 203 |
| Tracking since | Nov 16, 2022 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
ANI Pharmaceuticals, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Prochlorperazine Maleate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Phenothiazine class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PROCHLORPERAZINE 10 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for PROCHLORPERAZINE 10 MG TAB, manufactured by ANI Pharmaceuticals, Inc., is $0.1621 per EA (NDC 70954068910), effective Sep 30, 2026.
How has the price of PROCHLORPERAZINE 10 MG TAB changed over time?
Over the history we have for it, the NADAC for PROCHLORPERAZINE 10 MG TAB has declined 61.9%. It has been tracked across 203 weekly CMS publications since Nov 16, 2022.
What are the highest and lowest recorded NADAC prices for PROCHLORPERAZINE 10 MG TAB?
Since Nov 16, 2022, the NADAC for PROCHLORPERAZINE 10 MG TAB has ranged from a low of $0.1493 (Nov 20, 2024) to a high of $0.4384 (Apr 12, 2023), with a median of $0.2173 per EA.
Are there cheaper alternatives to PROCHLORPERAZINE 10 MG TAB?
7 manufacturers publish a NADAC-priced product with the same active ingredient and strength as PROCHLORPERAZINE 10 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures PROCHLORPERAZINE 10 MG TAB?
PROCHLORPERAZINE 10 MG TAB (NDC 70954068910) is labeled by ANI Pharmaceuticals, Inc., and CMS classifies it as a generic product.